speb/financial-data huggingface dataset:
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 465000000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Net PPE: 6198985000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -288213000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -79193000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 19943453000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 163136000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 4379252000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 108844000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 153208000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 107618000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 9713126000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Normalized Income: 7094254746.20
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 7790058000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Operating Income: 7654416000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Operating Revenue: 35302681000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1606400000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 343100000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 24029400000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 3840526000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 465757000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Investments: 942000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -25550000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 72800000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 146700000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 115838000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2338683000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Payable: 61332000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Properties: 6102300000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 161889000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 3560821000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Other Special Charges: 17832000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Payables: 4871942000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 463139000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1649251000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Pretax Income: 7908328000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 52903000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -945614000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -21081252000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -405851000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 824220000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 11821367000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1859000000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 112440000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 112440000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -412651000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -2290970000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 38509000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 59000000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 18178716000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 20280574000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 117638000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 7552985000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 7901012000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Share Issued: 436500000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 333458000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -412651000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Special Income Charges: -18874000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 6373000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 24465879000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 19943453000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 12990746.20
EMAMILTD.NS income_statement (annual, 2024-03-31) — Tax Provision: 666968000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.08
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 9300000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1462931000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Assets: 32797020000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 24465879000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Debt: 939559000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 24577101000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Total Expenses: 27648265000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 8219919000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 18614851000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 631653000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 233648000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 154033000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 154033000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Work In Process: 43908000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Working Capital: 6593903000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Write Off: 1042000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 4596500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 4871700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1658800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 263900000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 690800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 7592700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 26287000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 88300000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 17712300000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 123500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 480000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 603500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 9029800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 977200000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 4062400000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 5899700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3527900000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 26767000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 514500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1658800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Investmentsin Associatesat Cost: 1169700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 140400000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 140400000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 1169700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 190100000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: -13800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 5899700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 22224600000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 4788500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 96400000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1659800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 485400000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 25850500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 3380500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Investments: 1532900000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 111700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 138000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 5811400000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 49500000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 6901900000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Payables: 4968300000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 436500000.00
EMAMILTD.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 26287000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 22224600000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 10700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 35937000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 26287000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 743900000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 26273200000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 9663800000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 18224700000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 634000000.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 371800000.00
EMAMILTD.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
EMAMILTD.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
EMAMILTD.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 8682500000.00
EMAMILTD.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
EMAMILTD.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
EMAMILTD.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — +Operating Expense: 17680600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 4587100000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — +Total Revenue: 38091900000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 9630500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 4355991000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4355991000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 4512945000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 4512945000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -6946172000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6946172000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 17435000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 17435000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -165847000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -165847000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Amortization: 925500000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Amortization: 227500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 925535000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 669748000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 669748000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 436396104.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 435940860.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Basic EPS: 18.48
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.72
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 529500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 4219628000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 4219628000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -445700000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 277062000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 277062000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1046251000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1046251000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7437679000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7437679000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -3492000000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 211121000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 211121000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 835130000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 835130000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 153000000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 156100000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Change In Payable: -51800000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 439300000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 461500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 561200000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 26947929000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 26947929000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 165884000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 165884000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 11942300000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3284300000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Assets: 17336638000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 17336638000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 104243000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 104243000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Debt: 620847000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 620847000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 725090000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 725090000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 178341000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 178341000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 7793492000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7793492000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 853238000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 853238000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Depreciation: 1782100000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1782100000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1782100000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 435300000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 856600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 207800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 436396104.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 435940860.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Diluted EPS: 18.48
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.72
EMAMILTD.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 8064600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1621700000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 27998000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 27998000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 12800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — EBIT: 9032000000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — EBIT: 1964800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — EBITDA: 10814100000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — EBITDA: 2400100000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -44400000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1046300000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 731903000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 731903000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -4996100000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 1676262000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1676262000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 8513100000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -398500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 1900000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 539948000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 3620933000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3620933000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 4678792000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 4678792000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 12840945000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 12840945000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Gross Profit: 26149600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 6346200000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 0.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Interest Expense: 93400000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 27800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 93400000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 27800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Interest Income: 199964000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 199964000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -92500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 169400000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Inventory: 3081026000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 3081026000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 27568776000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 27568776000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3401500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 510809000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 510809000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 1401651000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1401651000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 1118901000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 1118901000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 1377300000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 614486000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 614486000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 172819000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 172819000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 172819000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 172819000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 1118901000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1118901000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 192900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 192900000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 7840947000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 7840947000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Minority Interest: -14343000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -14343000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Minority Interests: 37200000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Income: 8064600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Income: 1621700000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 8064600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1621700000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 8027400000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1621700000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 8064600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1621700000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 8064600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1621700000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 8938600000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 8027400000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1621700000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Interest Income: -93400000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -27800000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -3079400000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -36100000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -93400000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -27800000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -1225300000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Net PPE: 5894773000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 5894773000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -434300000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -36100000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 23326996000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 23326996000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 128942000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 128942000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 5239325000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 5239325000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 84068000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 84068000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 192919000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 192919000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 128752000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 10814100000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2400100000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Normalized Income: 8064600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1621700000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 8958800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Operating Income: 8469000000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Operating Income: 1759100000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Operating Revenue: 38091900000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 9630500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1431500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1431500000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 423000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 423000000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 26511400000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 26511400000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 2939033000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2939033000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 454909000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 454909000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Investments: 317000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Investments: 317000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -106600000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 95200000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 95200000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 128900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 128900000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 681100000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 211600000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 4488100000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1156700000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Payable: 653230000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 653230000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Properties: 5728900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 5728900000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 184618000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 184618000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 6391428000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 6391428000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Other Special Charges: 1881000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Payables: 5283982000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Payables: 5283982000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 548948000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 548948000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1468656000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1468656000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Pretax Income: 8938600000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1937000000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 7400000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -26890500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -445700000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 890415000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 890415000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 11942300000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3284300000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1782100000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 435300000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 135064000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 135064000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1413400000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 651714000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 651714000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 20945616000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 20945616000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 23811100000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 11400000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 6940200000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1888800000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 6940200000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1888800000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Share Issued: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 436500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 1377300000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -1413400000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 5000000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 26947929000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 26947929000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 23326996000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 23326996000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Tax Provision: 911200000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 315300000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.10
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.16
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 4500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 4500000.00
EMAMILTD.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1848000000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Assets: 35336253000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 35336253000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 26947929000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 26947929000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Debt: 897909000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 897909000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 26933586000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 26933586000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Total Expenses: 29622900000.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 7871400000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 8402667000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8402667000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 17999615000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 17999615000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 609175000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 609175000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 246763000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 246763000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Work In Process: 59440000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 59440000.00
EMAMILTD.NS balance_sheet (annual, 2025-03-31) — Working Capital: 9543146000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 9543146000.00
EMAMILTD.NS income_statement (annual, 2025-03-31) — Write Off: 489000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 4579100000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 9040900000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Amortization: 227800000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 436861702.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 3.76
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2764600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 445000000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 217200000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 436861702.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.76
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — EBIT: 1892000000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — EBITDA: 2337000000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 6276300000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 24300000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 24300000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Income: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -24300000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -24300000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2337000000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 1642600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Operating Income: 1697200000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 9040900000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 215900000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1142000000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 1867700000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2764600000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 445000000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1797500000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1797500000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 225100000.00
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.12
EMAMILTD.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 7343700000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 4338800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 7985100000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4219000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3722200000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Amortization: 230400000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1842500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 436323529.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 3.40
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 301600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 730300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8902100000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 29308300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 184200000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2313700000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 18584500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 138600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 418000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 556600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Deferred Taxes Liabilities: 129100000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 6785200000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 829800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 452700000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 222300000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 436323529.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.40
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — EBIT: 1528100000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1980800000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3167500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5731900000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 5671400000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 26300000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 26300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 4077300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 29726300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 456900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1842500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 1079600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 163000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 163000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1079600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 244900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: -14800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Income: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -26300000.00